Technology

September 10, 2009 – NI Medical Ltd. said yesterday it received FDA approval for its NICaS CS, a new device for the assessment of left ventricular systolic dysfunction (LVSD), to detect heart failure in its preclinical, asymptomatic phase.

Home September 10, 2009
Home
News

September 9, 2009 – As September is national peripheral arterial disease (or PAD) awareness month, the Society of Interventional Radiology is highlighting recent medical research addressing the seriousness of PAD available in the libraries for interventional radiologists and primary care physicians.

Home September 09, 2009
Home
Technology

The Arrow AutoCAT 2 WAVE Interaotic balloon pump (IABP) System provides counterpulsation support to the most unstable of IABP patients, those with tachyarrhythmias and variable pulse pressures, all while maintaining 1:1 assist and with full volume delivery to the catheter.

Home September 09, 2009
Home
Technology

September 9, 2009 – Royal Philips Electronics unveiled its PageWriter TC50 cardiograph, which uses gender-differentiated criteria to assist in the diagnosis of heart disease in women, where symptoms may be different from men. The PageWriter TC50 was launched at the European Society of Cardiology (ESC) Congress 2009 Aug. 28.

Home September 09, 2009
Home
Feature

September 9, 2009 - TeraMedica Healthcare Technology, a Milwaukee-based medical informatics company, announced the USPTO granted it the U.S. patent number 7,583,861 for its Evercore Smartstore solution, a clinical data management technology.

Home September 09, 2009
Home
News

September 9, 2009 – ProSolv CardioVascular enhanced its outcome reporting capabilities by partnering with Cedaron Medical Inc., a developer of quality measurement solutions, to provide the complete registry support that facilities need for ACC, national, and state clinical performance reporting.

Home September 09, 2009
Home
News

September 9, 2009 – Abiomed Inc. said today its percutaneous Impella ventricular assist device will be highlighted in several clinical sessions at the upcoming TCT 2009 scientific meeting Sept. 21-25, in San Francisco.

Home September 09, 2009
Home
News

September 9, 2009 – CardiacAssist Inc. said yesterday it will exhibit its TandemHeart System in San Francisco at the TCT 2009 and will highlight speakers who have used the device in their cath labs.

Home September 09, 2009
Home
News

September 8, 2009 – Endosense, a medical technology company focused on improving the efficacy, safety and reproducibility of catheter ablation for the treatment of cardiac arrhythmias, said last week it received $36 million in financing to fund the European commercialization and U.S. premarket approval (PMA) clinical study of the company’s TactiCath force-sensing ablation catheter.

Home September 08, 2009
Home
Technology

September 8, 2009 – Actelion Pharmaceuticals U.S. Inc. recently announced the first commercial sales of a new 20 microgram per milliliter (mcg/mL) formulation of Ventavis, for the treatment of New York Heart Association Class III and IV pulmonary arterial hypertension (PAH).

Home September 08, 2009
Home
News

September 8, 2009 – Siemens Healthcare and SurgiVision Inc. today announced an agreement for the codevelopment and commercialization of a real-time magnetic resonance image (MRI)-guided cardiac electrophysiology (EP) system.

Home September 08, 2009
Home
Technology

The HI-TORQUE Balance Middle Weight (BMW) Universal II Guide Wire offers the same performance of Abbott’s HT BMW UNIVERSAL wire, but includes the two advanced coating technologies and better coating durability for longer procedures

Home September 03, 2009
Home
Technology

The Perclose ProGlide 6 Fr. Suture-Mediated Closure System delivers a secure, reliable vessel closure to provide complete tissue apposition resulting in primary healing, reduces time to hemostasis, ambulation and discharge, and does not have any reaccess restrictions.

Home September 03, 2009
Home
News

September 3, 2009 – Percutaneous cardiac valve maker Evalve Inc. announced treatment this week of the first group of patients with the MitraClip system at the Karolinska University Hospital in Solna, Stockholm, Sweden.

Home September 03, 2009
Home
News

September 3, 2009 – Important new findings in patients with angina participating in the BEAUTIFUL study show that there is a 42 percent reduction in heart attack with Procoralan (ivabradine), as presented today at the European Society of Cardiology (ESC) Congress.

Home September 03, 2009
Home
Subscribe Now